Company / Revenue per Share
Amgen Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$68.45
FY2025
5-year range
$40.40 / $68.45
FY2021-FY2025
Trend
+9.6%
vs FY2024
Sector context
#6 of 154
Health Care
What the data says
Among 154 Health Care companies, Amgen is in the top 4% for revenue per share. Revenue per Share has increased for 9 consecutive years, from $26.61 in FY2016 to $68.45 in FY2025.
Based on SEC 10-K filings.
68.45 in FY2025 with a 5-year CAGR of +11.3%. Top quartile in the Health Care sector.
Improved from $52.79 to $68.45 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +14.6%
- 5-Year CAGR
- +11.3%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 154This company $68.45 Sector average $15.09
▼
+353.6% above sector average
Key checks
Key Insights
- Amgen's revenue per share has grown for 9 consecutive years.
- In FY2025, revenue per share increased 9.6% year-over-year.
- Ranks #6 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $68.45 | +9.6% |
| FY2024 | $62.43 | +18.3% |
| FY2023 | $52.79 | +15.9% |
| FY2022 | $45.54 | +12.7% |
| FY2021 | $40.40 | +0.6% |
| FY2020 | $40.15 | +10.6% |
| FY2019 | $36.29 | +14.0% |
| FY2018 | $31.83 | +8.5% |
| FY2017 | $29.34 | +10.3% |
| FY2016 | $26.61 | -6.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026